BRIEF published on 06/18/2026 at 07:35, 2 days 10 hours ago ABIONYX Pharma successfully completes its capital increase Capital Increase Clinical Trial Bond Financing Sepsis Fenja Capital
BRIEF published on 06/18/2026 at 07:35, 2 days 10 hours ago ABIONYX Pharma Completes Successful EUR 33 Million Financing Capital Increase Bond Financing ABIONYX Pharma Fenja Capital Sepsis Research
PRESS RELEASE published on 06/18/2026 at 07:30, 2 days 10 hours ago Inside Information / Other news releases ABIONYX Pharma successfully completes financing, raising EUR 33 M. Capital increase and bonds financing secured, enhancing financial position for future growth and clinical trials Financing Clinical Trials Capital Increase ABIONYX Pharma Bonds Financing
BRIEF published on 05/28/2026 at 19:11, 22 days 22 hours ago ABIONYX Pharma: Review of the first quarter of 2026 Revenue Treasury Funding Innovative Therapies Sepsis
BRIEF published on 05/28/2026 at 19:11, 22 days 22 hours ago ABIONYX Pharma Reports Stable First Quarter and Robust Financing for Future Growth Clinical Trials Capital Increase Financial Stability ABIONYX Pharma Revenue 2026
PRESS RELEASE published on 05/28/2026 at 19:06, 22 days 22 hours ago Inside Information / Other news releases ABIONYX Pharma updates its operations and cash position for Q1 2026. Consolidated revenue of €0.8M, cash reserves of €2.8M. Funding secured till 2028 through capital increase and non-dilutive loan Revenue Cash Position Funding ABIONYX Pharma Q1 2026
PRESS RELEASE published on 05/27/2026 at 07:30, 24 days 10 hours ago Inside Information / Other news releases ABIONYX Pharma launches a fully secured capital increase with preferential subscription rights and structured debt financing for up to EUR 33M. Finnja Capital commits EUR 10M in a non-dilutive loan Capital Increase Preferential Subscription Rights ABIONYX Pharma Fenja Capital Structured Debt Financing
BRIEF published on 04/08/2026 at 23:59, 2 months 11 days ago ABIONYX Reports Share Capital and Voting Rights Details Euronext Paris Share Capital Voting Rights Financial Disclosure ABIONYX
PRESS RELEASE published on 04/08/2026 at 23:54, 2 months 11 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares for March 31, 2026, in accordance with French regulations Shares French Regulations Total Voting Rights Biotech Company ABIONYX Pharma
BRIEF published on 03/17/2026 at 19:31, 3 months 2 days ago ABIONYX Pharma makes available the 2025 Universal Registration Document AMF Biopharmaceutical Registration Document ABIONYX Pharma Sepsis
Published on 06/20/2026 at 01:00, 16 hours 44 minutes ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 17 hours 44 minutes ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 13 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 16 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 16 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 06:00, 11 hours 44 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 21 hours 26 minutes ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 22 hours 43 minutes ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:00, 23 hours 44 minutes ago Successful issue of a CHF 100 million green bond
Published on 06/19/2026 at 19:33, 22 hours 11 minutes ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 22 hours 20 minutes ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 1 day 23 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 1 day 23 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
